Timing of Treatment with the Flavonoid 7,8-DHF Critically Impacts on Its Effects on Learning and Memory in the Ts65Dn Mouse
No therapies currently exist for intellectual disability in Down syndrome (DS). In view of its similarities with DS, including learning and memory (L&M) defects, the Ts65Dn mouse model of DS is widely used for the design of therapy. 7,8-dihydroxyflavone (7,8-DHF), a flavonoid that targets the tr...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Book |
| Published: |
MDPI AG,
2019-06-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_d3ec5d19fa214e058714dcda5341dba4 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Andrea Giacomini |e author |
| 700 | 1 | 0 | |a Fiorenza Stagni |e author |
| 700 | 1 | 0 | |a Marco Emili |e author |
| 700 | 1 | 0 | |a Beatrice Uguagliati |e author |
| 700 | 1 | 0 | |a Roberto Rimondini |e author |
| 700 | 1 | 0 | |a Renata Bartesaghi |e author |
| 700 | 1 | 0 | |a Sandra Guidi |e author |
| 245 | 0 | 0 | |a Timing of Treatment with the Flavonoid 7,8-DHF Critically Impacts on Its Effects on Learning and Memory in the Ts65Dn Mouse |
| 260 | |b MDPI AG, |c 2019-06-01T00:00:00Z. | ||
| 500 | |a 2076-3921 | ||
| 500 | |a 10.3390/antiox8060163 | ||
| 520 | |a No therapies currently exist for intellectual disability in Down syndrome (DS). In view of its similarities with DS, including learning and memory (L&M) defects, the Ts65Dn mouse model of DS is widely used for the design of therapy. 7,8-dihydroxyflavone (7,8-DHF), a flavonoid that targets the tropomyosin-related kinase B (TrkB) receptor of brain-derived neurotrophic factor (BDNF), exerts positive effects in various brain disease models. Based on previous demonstration that administration of 7,8-DHF in the postnatal period P3-P15 restores hippocampal neurogenesis and spinogenesis, we sought to establish whether these effects translate into behavioral benefits after treatment cessation. We found that Ts65Dn mice treated with 7,8-DHF (5.0 mg/kg/day) during postnatal days P3-P15 did not show any L&M improvement at one month after treatment cessation, indicating that the effects of 7,8-DHF on the brain are ephemeral. Based on evidence that chronic treatment with 7,8-DHF in juvenile Ts65Dn mice restores L&M, we sought to establish whether a similar effect is elicited in adulthood. We found that Ts65Dn mice treated with 7,8-DHF (5.0 mg/kg/day) for about 40 days starting from 4 months of age did not show any improvement in L&M. The results suggest that timing of therapy with 7,8-DHF is a critical issue for attainment of positive effects on the brain. | ||
| 546 | |a EN | ||
| 690 | |a Down syndrome | ||
| 690 | |a Ts65Dn mouse | ||
| 690 | |a Cognitive impairment | ||
| 690 | |a Therapy | ||
| 690 | |a Flavonoids | ||
| 690 | |a 7,8-dihydroxyflavone | ||
| 690 | |a Learning and memory | ||
| 690 | |a Therapeutics. Pharmacology | ||
| 690 | |a RM1-950 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n Antioxidants, Vol 8, Iss 6, p 163 (2019) | |
| 787 | 0 | |n https://www.mdpi.com/2076-3921/8/6/163 | |
| 787 | 0 | |n https://doaj.org/toc/2076-3921 | |
| 856 | 4 | 1 | |u https://doaj.org/article/d3ec5d19fa214e058714dcda5341dba4 |z Connect to this object online. |